GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Auxilium Pharmaceuticals, Inc. (AUXL) [hlAlert]

Rating:
Neutral AUXL
up 5.02 %

Auxilium Pharmaceuticals, Inc. (AUXL) downgraded to Neutral by MKM Partners

Posted on: Friday,  Oct 10, 2014  11:25 AM ET by MKM Partners

MKM Partners rated Neutral Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on 10/10/2014. Previously MKM Partners rated Buy Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on
09/17/2014., when the stock price was $30.47. Since then, Auxilium Pharmaceuticals, Inc. has gained 5.02% as of 10/10/2014's recent price of $32.00.
If you would have followed the previous MKM Partners's recommendation on AUXL, you would have gained 5.02% of your investment in 23 days.

Auxilium Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets products for urology and sexual health. Auxilium markets Testim 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions, as well as other products for urology and sexual health, including an enzyme in Phase II for the treatment of Peyronie's Disease that may also prove useful for the treatment of Dupuytren's Disease.

MKM Partners LLC is an institutional equity trading and research firm. MKM Partners has extensive experience in the agency execution of U.S. and international equity orders. We provide clients with timely and unbiased economic, technical, and fundamental research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/10/2014 11:25 AM Hold
None
32.00
as of 10/17/2014
1 Week up  0.72 %
1 Month up  5.02 %
3 Months up  5.02 %
1 YTD up  53.54 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/17/2014 11:25 AM Buy
None
30.47 32.00
3/3/2014 11:25 AM Hold
None
30.79 29.00
9/10/2013 11:25 AM Buy
None
18.21 22.00
4/30/2013 11:25 AM Hold
None
14.48 18.00
8/1/2012 11:25 AM Hold
None
25.40
5/22/2012 11:25 AM Buy
None
19.13 21.00
9/9/2011 11:25 AM Hold
None
15.89 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy